# Senti Biosciences Holdings, Inc.: Form SCHEDULE 13D/A, filed Jul 16, 2026

- Company: [Senti Biosciences Holdings, Inc.](/companies/snti.md) (CIK 1854270)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-16
- Accepted by EDGAR: Jul 16, 2026, 13:56 ET
- Period: not reported
- Accession: 0000902664-26-003126
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1854270/000090266426003126/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1854270/000090266426003126/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1854270/000090266426003126/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 16, 2026.
Source: SEC EDGAR, the filing index for accession 0000902664-26-003126. Last ingested by Listed: Oct 27, 2026, 16:38 ET. No prices; not investment advice.